Zurich Cantonal Bank
CRNX icon

Zurich Cantonal Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History

Zurich Cantonal Bank’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$989K Hold
26,439
– – ﹤0.01% 1560
2026
Q1 		$960K Buy
+26,439
New +$1.18M ﹤0.01% 1460
2025
Q4 		– Sell
-18,639
Closed -$830K – 2798
2025
Q3 		$776K Buy
18,639
+2,558
+16% +$81.8K ﹤0.01% 1457
2025
Q2 		$462K Buy
16,081
+1,389
+9% +$42.9K ﹤0.01% 1713
2025
Q1 		$493K Sell
14,692
-403
-3% -$15.1K ﹤0.01% 1607
2024
Q4 		$772K Buy
15,095
+2,970
+24% +$166K ﹤0.01% 1354
2024
Q3 		$620K Sell
12,125
-10
-0.1% -$516 ﹤0.01% 1425
2024
Q2 		$544K Buy
12,135
+2,952
+32% +$136K ﹤0.01% 1433
2024
Q1 		$430K Buy
9,183
+509
+6% +$19.9K ﹤0.01% 1570
2023
Q4 		$309K Sell
8,674
-1,515
-15% -$46.5K ﹤0.01% 1826
2023
Q3 		$303K Hold
10,189
– – ﹤0.01% 1694
2023
Q2 		$184K Buy
10,189
+2,321
+29% +$46.3K ﹤0.01% 1986
2023
Q1 		$126K Buy
7,868
+627
+9% +$11.6K ﹤0.01% 2158
2022
Q4 		$133K Sell
7,241
-164
-2% -$2.89K ﹤0.01% 2088
2022
Q3 		$145K Hold
7,405
– – ﹤0.01% 1955
2022
Q2 		$138K Sell
7,405
-88
-1% -$1.76K ﹤0.01% 2021
2022
Q1 		$164K Buy
7,493
+1,110
+17% +$22.5K ﹤0.01% 2015
2021
Q4 		$181K Buy
+6,383
New +$157K ﹤0.01% 2128

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zurich Cantonal Bank's CRNX Position: Q2 2026 in Review

Zurich Cantonal Bank held its Crinetics Pharmaceuticals (CRNX) position steady in Q2 2026 at 26,439 shares worth $989K. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

Zurich Cantonal Bank first reported a position in CRNX in Q4 2021 and has held it in 18 quarters since. 266 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Zurich Cantonal Bank held 26,439 shares of Crinetics Pharmaceuticals worth $989K as of Q2 2026.
  • Zurich Cantonal Bank left its Crinetics Pharmaceuticals share count unchanged in Q2 2026.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1560 holding.
  • Zurich Cantonal Bank first reported a position in Crinetics Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • 266 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.